<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Refeeding Syndrome - Disorder Mechanisms</title>
    <style>
        :root {
            --primary: #0f766e;
            --primary-light: #14b8a6;
            --primary-dark: #0d5c56;
            --secondary: #6366f1;
            --bg: #f0fdfa;
            --card-bg: #ffffff;
            --text: #134e4a;
            --text-muted: #5f7a78;
            --border: #ccfbf1;
            --accent-orange: #f59e0b;
            --accent-rose: #f43f5e;
            --accent-violet: #8b5cf6;
            --accent-sky: #0ea5e9;
            --banner-bg: #fef3c7;
            --banner-border: #f59e0b;
            --banner-text: #92400e;
        }

        * { box-sizing: border-box; margin: 0; padding: 0; }

        body {
            font-family: 'Segoe UI', system-ui, -apple-system, sans-serif;
            background: var(--bg);
            color: var(--text);
            line-height: 1.7;
        }

        .notice-banner {
            background: var(--banner-bg);
            color: var(--banner-text);
            border-bottom: 1px solid var(--banner-border);
            padding: 12px 16px;
            text-align: center;
            font-size: 0.95rem;
            cursor: pointer;
        }

        .container {
            max-width: 1100px;
            margin: 0 auto;
            padding: 24px;
        }

        /* Header */
        .page-header {
            background: linear-gradient(135deg, var(--primary) 0%, var(--primary-dark) 100%);
            color: white;
            padding: 40px 32px;
            border-radius: 16px;
            margin-bottom: 24px;
            position: relative;
            overflow: hidden;
        }

        .page-header::before {
            content: '';
            position: absolute;
            top: -50%;
            right: -20%;
            width: 400px;
            height: 400px;
            background: rgba(255,255,255,0.05);
            border-radius: 50%;
        }

        .page-header h1 {
            font-size: 2.2rem;
            font-weight: 700;
            margin-bottom: 12px;
            position: relative;
        }

        .header-meta {
            display: flex;
            flex-wrap: wrap;
            gap: 12px;
            align-items: center;
            position: relative;
        }

        .badge {
            display: inline-flex;
            align-items: center;
            padding: 6px 14px;
            border-radius: 20px;
            font-size: 0.85rem;
            font-weight: 500;
        }

        .badge-category {
            background: rgba(255,255,255,0.2);
            color: white;
        }

        .badge-mondo {
            background: var(--accent-sky);
            color: white;
        }

        .badge-mondo a {
            color: inherit;
            text-decoration: none;
        }

        .badge-mondo a:hover {
            text-decoration: underline;
        }

        /* Navigation */
        .breadcrumb {
            margin-bottom: 16px;
            font-size: 0.9rem;
        }

        .breadcrumb a {
            color: var(--primary);
            text-decoration: none;
        }

        .breadcrumb a:hover {
            text-decoration: underline;
        }

        .breadcrumb span {
            color: var(--text-muted);
        }

        /* Cards */
        .card {
            background: var(--card-bg);
            border-radius: 12px;
            border: 1px solid var(--border);
            padding: 24px;
            margin-bottom: 20px;
            box-shadow: 0 1px 3px rgba(0,0,0,0.04);
        }

        .card-header {
            display: flex;
            align-items: center;
            gap: 12px;
            margin-bottom: 16px;
            padding-bottom: 12px;
            border-bottom: 2px solid var(--border);
        }

        .card-icon {
            width: 36px;
            height: 36px;
            border-radius: 8px;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 1.2rem;
        }

        .card-title {
            font-size: 1.1rem;
            font-weight: 600;
            color: var(--text);
        }

        .card-count {
            margin-left: auto;
            background: var(--bg);
            padding: 4px 12px;
            border-radius: 12px;
            font-size: 0.8rem;
            color: var(--text-muted);
        }

        /* Sections */
        .section-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(320px, 1fr));
            gap: 20px;
        }

        /* Tags */
        .tag-list {
            display: flex;
            flex-wrap: wrap;
            gap: 8px;
        }

        .tag {
            padding: 6px 12px;
            border-radius: 6px;
            font-size: 0.85rem;
            font-weight: 500;
        }

        .tag-cell {
            background: #fce7f3;
            color: #9d174d;
        }

        .tag-gene {
            background: #dbeafe;
            color: #1e40af;
        }

        .tag-treatment {
            background: #ede9fe;
            color: #5b21b6;
        }

        .tag-env {
            background: #ccfbf1;
            color: #0f766e;
        }

        .tag-location {
            background: #e0e7ff;
            color: #3730a3;
        }

        .tag-component {
            background: #f0fdf4;
            color: #166534;
        }

        .tag-complex {
            background: #faf5ff;
            color: #7e22ce;
        }

        .tag-bio {
            background: #fef3c7;
            color: #92400e;
        }

        .tag-modifier {
            background: #fee2e2;
            color: #991b1b;
            text-transform: uppercase;
            letter-spacing: 0.02em;
        }

        .tag-parent {
            background: #e0e7ff;
            color: #3730a3;
        }

        .tag-classification {
            background: #fef3c7;
            color: #92400e;
        }

        .tag-mechanistic {
            background: #dbeafe;
            color: #1e40af;
        }

        .linkout {
            color: inherit;
            margin-left: 6px;
            font-size: 0.75rem;
            text-decoration: none;
            border-bottom: 1px dotted rgba(0, 0, 0, 0.2);
        }

        .classification-category {
            font-size: 0.75rem;
            font-weight: 600;
            text-transform: uppercase;
            letter-spacing: 0.05em;
            color: var(--text-muted);
            margin-bottom: 8px;
        }

        .mapping-section {
            margin-bottom: 16px;
        }

        .mapping-item {
            padding: 10px 12px;
            border: 1px solid #e2e8f0;
            border-radius: 8px;
            background: #ffffff;
            margin-bottom: 10px;
        }

        .mapping-title {
            font-size: 0.9rem;
            font-weight: 600;
            display: flex;
            flex-wrap: wrap;
            gap: 8px;
            align-items: baseline;
            margin-bottom: 6px;
        }

        .mapping-label {
            color: var(--text-muted);
            font-weight: 500;
        }

        .mapping-notes {
            font-size: 0.85rem;
            color: var(--text-muted);
            margin-top: 6px;
        }

        .mapping-tree {
            margin-top: 6px;
            font-size: 0.75rem;
            color: var(--text-muted);
            list-style: none;
            padding-left: 0;
        }

        .mapping-tree li {
            margin: 2px 0;
        }

        /* Evidence styling */
        .evidence-toggle {
            cursor: pointer;
            font-size: 0.8rem;
            color: var(--text-muted);
            margin-top: 10px;
            user-select: none;
        }

        .evidence-toggle:hover {
            color: var(--primary);
        }

        .evidence-list {
            margin-top: 10px;
            padding-left: 0;
        }

        .evidence-item {
            padding: 12px 14px;
            background: #f8fafc;
            border-radius: 8px;
            margin-bottom: 8px;
            border: 1px solid #e2e8f0;
            font-size: 0.9rem;
        }

        .evidence-header {
            display: flex;
            align-items: center;
            flex-wrap: wrap;
            gap: 8px;
        }

        .evidence-ref {
            font-weight: 600;
            color: var(--secondary);
        }

        .evidence-ref a {
            color: inherit;
            text-decoration: none;
        }

        .evidence-ref a:hover {
            text-decoration: underline;
        }

        .evidence-support {
            font-size: 0.7rem;
            padding: 2px 8px;
            border-radius: 4px;
            font-weight: 600;
            text-transform: uppercase;
            transition: transform 120ms ease, box-shadow 120ms ease;
        }

        .support-SUPPORT { background: #dcfce7; color: #166534; }
        .support-PARTIAL { background: #fef3c7; color: #92400e; }
        .support-REFUTE { background: #fee2e2; color: #991b1b; }
        .support-NO_EVIDENCE { background: #f1f5f9; color: #64748b; }
        .support-WRONG_STATEMENT { background: #fecaca; color: #7f1d1d; }

        .evidence-source {
            font-size: 0.7rem;
            padding: 2px 8px;
            border-radius: 4px;
            font-weight: 600;
            text-transform: uppercase;
            background: #e2e8f0;
            color: #334155;
            transition: transform 120ms ease, box-shadow 120ms ease;
        }

        .evidence-support:hover,
        .evidence-source:hover {
            transform: translateY(-1px);
            box-shadow: 0 4px 10px rgba(0,0,0,0.08);
        }

        .source-HUMAN_CLINICAL { background: #e0f2fe; color: #075985; }
        .source-MODEL_ORGANISM { background: #fef9c3; color: #854d0e; }
        .source-IN_VITRO { background: #ede9fe; color: #5b21b6; }
        .source-COMPUTATIONAL { background: #cffafe; color: #0e7490; }
        .source-OTHER { background: #e5e7eb; color: #374151; }

        .evidence-snippet {
            font-size: 0.85rem;
            color: var(--text-muted);
            margin-top: 8px;
            padding-left: 12px;
            border-left: 2px solid #cbd5e1;
            font-style: italic;
            line-height: 1.5;
        }

        .evidence-explanation {
            font-size: 0.85rem;
            color: var(--text);
            margin-top: 6px;
            line-height: 1.5;
        }

        .evidence-more {
            font-size: 0.8rem;
            color: var(--text-muted);
            margin-top: 6px;
            font-style: italic;
        }

        .findings-section {
            margin-top: 12px;
        }

        .findings-title {
            font-size: 0.75rem;
            font-weight: 600;
            text-transform: uppercase;
            letter-spacing: 0.04em;
            color: var(--text-muted);
            margin-bottom: 6px;
        }

        .finding-item {
            padding: 10px 12px;
            background: #f8fafc;
            border-radius: 8px;
            margin-bottom: 8px;
            border: 1px solid #e2e8f0;
            font-size: 0.9rem;
        }

        .finding-statement {
            font-weight: 600;
            color: var(--text);
            margin-bottom: 6px;
            line-height: 1.5;
        }

        .finding-supporting {
            font-size: 0.85rem;
            color: var(--text-muted);
            margin-top: 6px;
            padding-left: 12px;
            border-left: 2px solid #cbd5e1;
            font-style: italic;
            line-height: 1.5;
        }

        /* Item containers with evidence */
        .item-box {
            padding: 16px;
            border-radius: 10px;
            margin-bottom: 12px;
        }

        .item-name {
            font-weight: 600;
            margin-bottom: 6px;
        }

        .item-desc {
            font-size: 0.9rem;
            line-height: 1.6;
            margin-bottom: 8px;
        }

        .item-meta {
            display: flex;
            flex-wrap: wrap;
            gap: 6px;
            margin-top: 8px;
        }

        /* Definitions */
        .definition-box {
            background: #ecfeff;
            border-left: 4px solid #0ea5e9;
        }
        .definition-box .item-name { color: #0c4a6e; }
        .definition-box .item-desc { color: #075985; }

        /* Inheritance */
        .inheritance-box {
            background: #fef9c3;
            border-left: 4px solid #ca8a04;
        }
        .inheritance-box .item-name { color: #92400e; }
        .inheritance-box .item-desc { color: #92400e; }

        .criteria-block {
            margin-top: 12px;
            padding: 12px;
            border-radius: 8px;
            border: 1px solid #bae6fd;
            background: rgba(255, 255, 255, 0.7);
        }

        .criteria-title {
            font-weight: 600;
            color: #0c4a6e;
            margin-bottom: 6px;
        }

        .criteria-meta {
            font-size: 0.8rem;
            color: var(--text-muted);
            margin-bottom: 8px;
        }

        .criteria-header {
            font-size: 0.75rem;
            text-transform: uppercase;
            letter-spacing: 0.04em;
            color: #0284c7;
            margin-top: 8px;
        }

        .criteria-list {
            margin-left: 18px;
            font-size: 0.9rem;
            line-height: 1.5;
            color: #0f172a;
        }

        .criteria-list li {
            margin-bottom: 6px;
        }

        .criteria-detail {
            display: block;
            font-size: 0.85rem;
            color: var(--text-muted);
        }

        /* Pathophysiology */
        .pathophys-box {
            background: linear-gradient(135deg, #fef3c7 0%, #fef9c3 100%);
            border-left: 4px solid var(--accent-orange);
        }
        .pathophys-box .item-name { color: #92400e; }
        .pathophys-box .item-desc { color: #78350f; }

        /* Histopathology */
        .histopathology-box {
            background: #fff7ed;
            border-left: 4px solid #fb923c;
        }
        .histopathology-box .item-name { color: #9a3412; }
        .histopathology-box .item-desc { color: #c2410c; }

        .histopathology-freq {
            font-size: 0.75rem;
            padding: 2px 8px;
            border-radius: 10px;
            background: #ffedd5;
            color: #c2410c;
        }

        /* Phenotypes */
        .phenotype-box {
            background: #f0fdf4;
            border-left: 4px solid #22c55e;
        }
        .phenotype-box .item-name { color: #166534; }
        .phenotype-box .item-desc { color: #15803d; }

        .phenotype-freq {
            font-size: 0.75rem;
            padding: 2px 8px;
            border-radius: 10px;
            background: #dcfce7;
            color: #15803d;
        }

        .phenotype-category {
            font-size: 0.75rem;
            color: #4ade80;
        }

        .phenotype-id a {
            font-size: 0.8rem;
            color: var(--secondary);
            text-decoration: none;
        }

        .phenotype-id a:hover {
            text-decoration: underline;
        }

        /* Phenotype TOC strip */
        .pheno-toc {
            display: flex;
            flex-wrap: wrap;
            gap: 6px;
            padding: 10px 0 6px 0;
            border-bottom: 1px solid #e2e8f0;
            margin-bottom: 4px;
        }

        .pheno-toc-pill {
            display: inline-block;
            font-size: 0.78rem;
            padding: 3px 10px;
            border-radius: 12px;
            background: #dcfce7;
            color: #166534;
            text-decoration: none;
            cursor: pointer;
            white-space: nowrap;
            transition: background 0.15s;
        }

        .pheno-toc-pill:hover {
            background: #bbf7d0;
        }

        .pheno-toc-pill .pill-count {
            font-weight: 600;
            margin-left: 2px;
        }

        .pheno-toggle-all {
            font-size: 0.78rem;
            color: #16a34a;
            cursor: pointer;
            background: none;
            border: 1px solid #bbf7d0;
            border-radius: 6px;
            padding: 3px 10px;
            margin-left: auto;
            white-space: nowrap;
            transition: background 0.15s;
        }

        .pheno-toggle-all:hover {
            background: #f0fdf4;
        }

        /* Collapsible category groups */
        .phenotype-category-group {
            margin-bottom: 2px;
        }

        .phenotype-category-group summary {
            font-size: 0.85rem;
            font-weight: 600;
            text-transform: uppercase;
            letter-spacing: 0.04em;
            color: #16a34a;
            margin: 0;
            padding: 10px 0 6px 0;
            border-bottom: 1px solid #bbf7d0;
            cursor: pointer;
            list-style: none;
            display: flex;
            align-items: center;
            gap: 6px;
        }

        .phenotype-category-group summary::-webkit-details-marker {
            display: none;
        }

        .phenotype-category-group summary .chevron {
            display: inline-block;
            width: 16px;
            height: 16px;
            transition: transform 0.15s;
            flex-shrink: 0;
        }

        .phenotype-category-group[open] summary .chevron {
            transform: rotate(90deg);
        }

        .phenotype-category-group summary .cat-count {
            font-size: 0.75rem;
            font-weight: 400;
            color: #15803d;
            background: #dcfce7;
            padding: 1px 7px;
            border-radius: 8px;
        }

        /* Phenotype Contexts */
        .phenotype-contexts {
            margin-top: 10px;
        }

        .phenotype-contexts-toggle {
            font-size: 0.8rem;
            color: var(--text-muted);
            cursor: pointer;
            user-select: none;
        }

        .phenotype-contexts-toggle:hover {
            color: var(--primary);
        }

        .context-card {
            padding: 10px 14px;
            margin-top: 8px;
            border-radius: 8px;
            background: #ecfdf5;
            border: 1px solid #a7f3d0;
            font-size: 0.88rem;
        }

        .context-header {
            display: flex;
            flex-wrap: wrap;
            align-items: center;
            gap: 6px;
            margin-bottom: 6px;
        }

        .context-label {
            font-size: 0.72rem;
            font-weight: 600;
            text-transform: uppercase;
            letter-spacing: 0.04em;
            padding: 2px 8px;
            border-radius: 4px;
        }

        .context-label-genetic {
            background: #dbeafe;
            color: #1e40af;
        }

        .context-label-sex {
            background: #fce7f3;
            color: #9d174d;
        }

        .context-label-population {
            background: #fef3c7;
            color: #92400e;
        }

        .context-label-age {
            background: #e0e7ff;
            color: #3730a3;
        }

        .context-label-subtype {
            background: #ede9fe;
            color: #5b21b6;
        }

        .context-label-frequency {
            background: #dcfce7;
            color: #166534;
        }

        .context-gene-list {
            display: flex;
            flex-wrap: wrap;
            gap: 4px;
            margin: 4px 0;
        }

        .context-gene-tag {
            font-size: 0.78rem;
            font-weight: 600;
            padding: 1px 8px;
            border-radius: 4px;
            background: #bfdbfe;
            color: #1e3a8a;
        }

        .context-detail {
            font-size: 0.84rem;
            color: #065f46;
            line-height: 1.5;
        }

        .context-detail strong {
            color: #047857;
        }

        .context-freq {
            font-size: 0.75rem;
            padding: 2px 8px;
            border-radius: 10px;
            background: #bbf7d0;
            color: #14532d;
            font-weight: 600;
        }

        .context-onset {
            font-size: 0.75rem;
            padding: 2px 8px;
            border-radius: 10px;
            background: #e0e7ff;
            color: #3730a3;
        }

        .context-severity {
            font-size: 0.75rem;
            padding: 2px 8px;
            border-radius: 10px;
            background: #fef3c7;
            color: #92400e;
        }

        .context-notes {
            font-size: 0.84rem;
            color: #065f46;
            margin-top: 4px;
            line-height: 1.5;
        }

        /* Genetic */
        .genetic-box {
            background: #eff6ff;
            border-left: 4px solid #3b82f6;
        }
        .genetic-box .item-name { color: #1e40af; }
        .genetic-box .item-desc { color: #2563eb; }

        /* Treatment */
        .treatment-box {
            background: #faf5ff;
            border-left: 4px solid #8b5cf6;
        }
        .treatment-box .item-name { color: #5b21b6; }
        .treatment-box .item-desc { color: #7c3aed; }

        /* Environmental */
        .environmental-box {
            background: #f0fdfa;
            border-left: 4px solid #14b8a6;
        }
        .environmental-box .item-name { color: #0f766e; }
        .environmental-box .item-desc { color: #0d9488; }

        /* Biochemical */
        .biochemical-box {
            background: #fffbeb;
            border-left: 4px solid #f59e0b;
        }
        .biochemical-box .item-name { color: #92400e; }
        .biochemical-box .item-desc { color: #b45309; }

        /* Differential Diagnoses */
        .differential-box {
            background: #fef2f2;
            border-left: 4px solid #dc2626;
        }
        .differential-box .item-name { color: #7f1d1d; }
        .differential-box .item-desc { color: #b91c1c; }

        .differential-similarities {
            background: #fee2e2;
            border-left: 2px solid #dc2626;
            padding: 10px 12px;
            border-radius: 6px;
            margin: 8px 0;
            font-size: 0.9rem;
        }

        .differential-distinctions {
            background: #dcfce7;
            border-left: 2px solid #16a34a;
            padding: 10px 12px;
            border-radius: 6px;
            margin: 8px 0;
            font-size: 0.9rem;
        }

        .differential-similarities strong,
        .differential-distinctions strong {
            display: block;
            margin-bottom: 6px;
            font-size: 0.85rem;
            text-transform: uppercase;
            letter-spacing: 0.05em;
        }

        .differential-similarities ul,
        .differential-distinctions ul {
            margin-left: 16px;
            line-height: 1.6;
        }

        .differential-similarities li,
        .differential-distinctions li {
            margin: 4px 0;
            font-size: 0.9rem;
        }

        /* Datasets */
        .dataset-box {
            background: #f0f9ff;
            border-left: 4px solid #0284c7;
        }
        .dataset-box .item-name { color: #0c4a6e; }
        .dataset-box .item-desc { color: #0369a1; }

        .tag-dataset {
            background: #e0f2fe;
            color: #0369a1;
        }

        .tag-organism {
            background: #fae8ff;
            color: #a21caf;
        }

        .tag-datatype {
            background: #dbeafe;
            color: #1d4ed8;
        }

        /* Clinical Trials */
        .clinical-trial-box {
            background: #f5f3ff;
            border-left: 4px solid #a855f7;
        }
        .clinical-trial-box .item-name { color: #6b21a8; }
        .clinical-trial-box .item-desc { color: #7e22ce; }

        .tag-phase {
            background: #ede9fe;
            color: #6b21a8;
        }

        .tag-status {
            background: #fce7f3;
            color: #9d174d;
        }

        .trial-nct a {
            font-family: 'Fira Code', 'Consolas', monospace;
            font-size: 0.85rem;
            color: var(--secondary);
            text-decoration: none;
        }

        .trial-nct a:hover {
            text-decoration: underline;
        }

        .dataset-accession a {
            font-family: 'Fira Code', 'Consolas', monospace;
            font-size: 0.85rem;
            color: var(--secondary);
            text-decoration: none;
        }

        .dataset-accession a:hover {
            text-decoration: underline;
        }

        /* Subtypes */
        .subtype-box {
            background: #eef2ff;
            border-left: 4px solid var(--secondary);
        }
        .subtype-box .item-name { color: #3730a3; }
        .subtype-box .item-desc { color: #4f46e5; }
        .classification-header {
            font-size: 1rem;
            font-weight: 600;
            color: #4338ca;
            margin: 1.2rem 0 0.5rem 0;
            padding-bottom: 0.3rem;
            border-bottom: 2px solid #c7d2fe;
            text-transform: capitalize;
        }
        .subtype-meta {
            display: flex;
            flex-wrap: wrap;
            gap: 0.4rem;
            margin: 0.3rem 0;
        }
        .subtype-freq-badge {
            background: #dbeafe;
            color: #1e40af;
            padding: 0.15rem 0.5rem;
            border-radius: 9999px;
            font-size: 0.8rem;
            font-weight: 500;
        }
        .subtype-gene-tag {
            background: #fef3c7;
            color: #92400e;
            padding: 0.15rem 0.5rem;
            border-radius: 9999px;
            font-size: 0.8rem;
            font-weight: 500;
        }
        .subtype-inheritance-tag {
            background: #ede9fe;
            color: #5b21b6;
            padding: 0.15rem 0.5rem;
            border-radius: 9999px;
            font-size: 0.8rem;
            font-weight: 500;
        }
        .subtype-term-link {
            font-size: 0.8rem;
            color: #6366f1;
            text-decoration: none;
        }
        .subtype-term-link:hover { text-decoration: underline; }
        .subtype-children {
            margin: 0.4rem 0 0.2rem 1rem;
            padding: 0;
            list-style: none;
        }
        .subtype-children li {
            font-size: 0.85rem;
            color: #4338ca;
            padding: 0.1rem 0;
        }
        .subtype-children li::before {
            content: "↳ ";
            color: #a5b4fc;
        }

        /* Stats bar */
        .stats-bar {
            display: flex;
            gap: 24px;
            padding: 20px 24px;
            background: var(--card-bg);
            border-radius: 12px;
            border: 1px solid var(--border);
            margin-bottom: 24px;
            flex-wrap: wrap;
        }

        .stat-item {
            text-align: center;
        }

        .stat-link {
            text-decoration: none;
            color: inherit;
        }

        .stat-value {
            font-size: 1.5rem;
            font-weight: 700;
            color: var(--primary);
        }

        .stat-label {
            font-size: 0.8rem;
            color: var(--text-muted);
            text-transform: uppercase;
            letter-spacing: 0.05em;
        }

        /* YAML preview */
        .yaml-preview {
            background: #1e293b;
            color: #e2e8f0;
            padding: 20px;
            border-radius: 8px;
            overflow-x: auto;
            font-family: 'Fira Code', 'Consolas', monospace;
            font-size: 0.85rem;
            line-height: 1.5;
            max-height: 400px;
            overflow-y: auto;
        }

        .yaml-content {
            display: none;
        }

        .yaml-content.show {
            display: block;
        }

        /* Footer */
        .page-footer {
            margin-top: 40px;
            padding-top: 20px;
            border-top: 1px solid var(--border);
            text-align: center;
            color: var(--text-muted);
            font-size: 0.85rem;
        }

        .page-footer a {
            color: var(--primary);
            text-decoration: none;
        }

        .page-footer a:hover {
            text-decoration: underline;
        }

        /* Responsive */
        @media (max-width: 768px) {
            .page-header h1 { font-size: 1.6rem; }
            .stats-bar { gap: 16px; }
            .section-grid { grid-template-columns: 1fr; }
        }
        /* Mermaid graph */
        .mermaid-container {
            text-align: center;
            margin: 20px 0;
            padding: 20px;
            background: white;
            border-radius: 8px;
            border: 1px solid var(--border);
            overflow-x: auto;
        }

        .mermaid svg {
            max-width: 100%;
            height: auto;
        }

        .graph-warning {
            background: #fef3c7;
            border: 1px solid #f59e0b;
            border-radius: 8px;
            padding: 12px 16px;
            margin-bottom: 16px;
            font-size: 0.85rem;
            color: #92400e;
        }

        .graph-warning strong {
            display: block;
            margin-bottom: 4px;
        }

        .graph-warning ul {
            margin: 8px 0 0 20px;
            padding: 0;
        }

        .graph-warning li {
            margin: 4px 0;
        }
    </style>
    <script src="https://cdn.jsdelivr.net/npm/mermaid@10/dist/mermaid.min.js"></script>
    <script>
        mermaid.initialize({
            startOnLoad: true,
            theme: 'default',
            flowchart: {
                htmlLabels: true,
                curve: 'basis'
            }
        });
    </script>
</head>
<body>
    <div class="notice-banner" role="button" tabindex="0">This resource is in its pre-alpha development stage. Content is actively being curated and may be incomplete or subject to change.</div>
    

    

    
    

    
    

    

    

    

    

    

    <div class="container">
        <nav class="breadcrumb">
            <a href="../../app/index.html">Browse All</a>
            <span> / </span>
            <span>Refeeding Syndrome</span>
        </nav>

        <header class="page-header">
            <h1>Refeeding Syndrome</h1>
            <div class="header-meta">
                
                <span class="badge badge-category">Nutritional</span>
                
                
                <span class="badge badge-mondo">
                    <a href="http://purl.obolibrary.org/obo/MONDO_0400005" target="_blank">
                        MONDO:0400005
                    </a>
                </span>
                
                
                <span class="badge badge-category" style="background: rgba(255,255,255,0.1);">Nutritional Disorder</span>
                
            </div>
            
            <p style="margin-top: 16px; font-size: 1rem; line-height: 1.6; opacity: 0.95; position: relative;">
                A potentially dangerous constellation of metabolic disturbances that occurs when nutrition is reintroduced after a period of malnutrition or starvation, often with carbohydrate-driven shifts in electrolytes and fluid balance.
            </p>
            
        </header>

        <!-- Stats bar -->
        
        
        
        
        
        
        
        
        
        
        
        
        
        <div class="stats-bar">
            
            <div class="stat-item">
                <div class="stat-value">0</div>
                <div class="stat-label">Mappings</div>
            </div>
            
            
            <div class="stat-item">
                <div class="stat-value">0</div>
                <div class="stat-label">Definitions</div>
            </div>
            
            
            <div class="stat-item">
                <div class="stat-value">0</div>
                <div class="stat-label">Inheritance</div>
            </div>
            
            
            <a class="stat-link" href="#pathophysiology">
            <div class="stat-item">
                <div class="stat-value">11</div>
                <div class="stat-label">Pathophysiology</div>
            </div>
            </a>
            
            
            <a class="stat-link" href="#histopathology">
            <div class="stat-item">
                <div class="stat-value">1</div>
                <div class="stat-label">Histopathology</div>
            </div>
            </a>
            
            
            <a class="stat-link" href="#phenotypes">
            <div class="stat-item">
                <div class="stat-value">8</div>
                <div class="stat-label">Phenotypes</div>
            </div>
            </a>
            
            
            <div class="stat-item">
                <div class="stat-value">0</div>
                <div class="stat-label">Genes</div>
            </div>
            
            
            <a class="stat-link" href="#treatments">
            <div class="stat-item">
                <div class="stat-value">4</div>
                <div class="stat-label">Treatments</div>
            </div>
            </a>
            
            
            <div class="stat-item">
                <div class="stat-value">0</div>
                <div class="stat-label">Subtypes</div>
            </div>
            
            
            <a class="stat-link" href="#differentials">
            <div class="stat-item">
                <div class="stat-value">3</div>
                <div class="stat-label">Differentials</div>
            </div>
            </a>
            
            
            <div class="stat-item">
                <div class="stat-value">0</div>
                <div class="stat-label">Datasets</div>
            </div>
            
            
            <a class="stat-link" href="#trials">
            <div class="stat-item">
                <div class="stat-value">2</div>
                <div class="stat-label">Trials</div>
            </div>
            </a>
            
        </div>

        <!-- Classifications -->
        

        <!-- Mappings -->
        

        <!-- Definitions -->
        

        <!-- Inheritance -->
        

        <!-- Subtypes -->
        

        <!-- Comorbidities -->
        

        <!-- Pathophysiology -->
        
        <div class="card" id="pathophysiology">
            <div class="card-header">
                <div class="card-icon" style="background: #fef3c7; color: #d97706;">⚙</div>
                <h2 class="card-title">Pathophysiology</h2>
                <span class="card-count">11</span>
            </div>
            
            <div class="item-box pathophys-box">
                <div class="item-name">Pre-refeeding malnutrition state</div>
                
                <div class="item-desc">Patients who develop refeeding syndrome typically have been malnourished for days to weeks before nutrition is reintroduced.</div>
                
                
                
                
                
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/19278172" target="_blank">PMID:19278172</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"The typical patient who experiences RFS has been malnourished for days to weeks"</div>
                
                
                <div class="evidence-explanation">This describes the malnourished state that precedes refeeding syndrome.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box pathophys-box">
                <div class="item-name">Aggressive nutritional reintroduction</div>
                
                <div class="item-desc">Refeeding syndrome is triggered when aggressive enteral or parenteral feeding is initiated in a malnourished patient.</div>
                
                
                
                
                
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/19931071" target="_blank">PMID:19931071</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"Refeeding syndrome (RFS) is the result of aggressive enteral or parenteral feeding in a malnourished patient"</div>
                
                
                <div class="evidence-explanation">This identifies aggressive refeeding in malnourished patients as the precipitating step.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box pathophys-box">
                <div class="item-name">Hypophosphatemia as hallmark biochemical shift</div>
                
                <div class="item-desc">Hypophosphatemia is the hallmark biochemical change following refeeding.</div>
                
                
                
                
                
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/19931071" target="_blank">PMID:19931071</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"with hypophosphatemia being the hallmark of this phenomenon."</div>
                
                
                <div class="evidence-explanation">This explicitly labels hypophosphatemia as the hallmark feature of refeeding syndrome.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box pathophys-box">
                <div class="item-name">Hypophosphatemia at onset of refeeding syndrome</div>
                
                <div class="item-desc">Hypophosphatemia is observed at the onset of refeeding syndrome and is monitored during refeeding.</div>
                
                
                
                
                
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/36936877" target="_blank">PMID:36936877</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-MODEL_ORGANISM">Model Organism</span>
                    
                </div>
                
                <div class="evidence-snippet">"Hypophosphatemia inevitably is observed at the onset of refeeding syndrome and therefore is monitored during refeeding"</div>
                
                
                <div class="evidence-explanation">This notes that hypophosphatemia appears at onset and is monitored during refeeding.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box pathophys-box">
                <div class="item-name">Intracellular electrolyte shift during anabolism</div>
                
                <div class="item-desc">The metabolic response to refeeding drives an acute intracellular shift of electrolytes with increased phosphate demand for tissue anabolism and high- energy phosphate bond formation.</div>
                
                
                
                
                
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/19278172" target="_blank">PMID:19278172</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"acute intracellular shift in electrolytes, increased phosphate demand during tissue anabolism, and formation of high-energy phosphate bonds."</div>
                
                
                <div class="evidence-explanation">This directly describes the intracellular electrolyte shift and increased phosphate demand that drive refeeding syndrome.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box pathophys-box">
                <div class="item-name">Rapid post-feeding phosphate decline</div>
                
                <div class="item-desc">After initiation of parenteral nutrition, phosphate levels decline rapidly and more markedly than potassium or magnesium.</div>
                
                
                
                
                
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/40738722" target="_blank">PMID:40738722</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"Phosphate levels showed the most significant decline post-PN initiation (43%), followed by potassium (19%) and magnesium (17%)"</div>
                
                
                <div class="evidence-explanation">This quantifies the rapid decline in phosphate compared with potassium and magnesium after PN initiation.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box pathophys-box">
                <div class="item-name">Sodium and fluid retention</div>
                
                <div class="item-desc">Sodium and fluid retention occurs alongside electrolyte abnormalities during refeeding.</div>
                
                
                
                
                
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/19931071" target="_blank">PMID:19931071</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"along with sodium and fluid retention."</div>
                
                
                <div class="evidence-explanation">This identifies sodium and fluid retention as a common concurrent change.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box pathophys-box">
                <div class="item-name">Thiamine deficiency emerges during refeeding</div>
                
                <div class="item-desc">Thiamine deficiency is a common accompanying abnormality during refeeding.</div>
                
                
                
                
                
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/29448987" target="_blank">PMID:29448987</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"thiamine deficiency and disorder of sodium and fluid balance are common."</div>
                
                
                <div class="evidence-explanation">This identifies thiamine deficiency as a common accompanying feature.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box pathophys-box">
                <div class="item-name">Cardiorespiratory complications from metabolic derangements</div>
                
                <div class="item-desc">Severe metabolic derangements can progress to fatal arrhythmias, systolic heart failure, and respiratory insufficiency.</div>
                
                
                
                
                
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/19278172" target="_blank">PMID:19278172</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"fatal cardiac arrhythmia, systolic heart failure, respiratory insufficiency"</div>
                
                
                <div class="evidence-explanation">This lists the severe cardiorespiratory complications of refeeding syndrome.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box pathophys-box">
                <div class="item-name">Refeeding-induced central nervous system disorders</div>
                
                <div class="item-desc">Refeeding can precipitate central nervous system complications including hypoglycemic encephalopathy, Wernicke encephalopathy, and hypophosphatemic encephalopathy.</div>
                
                
                
                
                
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/41246683" target="_blank">PMID:41246683</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"Refeeding syndrome potentially causes death from refeeding-induced central nervous system disorders, such as hypoglycemic encephalopathy, Wernicke encephalopathy, and hypophosphatemic encephalopathy."</div>
                
                
                <div class="evidence-explanation">This case report highlights CNS complications associated with refeeding syndrome.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box pathophys-box">
                <div class="item-name">Abnormal myocardial fatty acid metabolism</div>
                
                <div class="item-desc">Abnormal myocardial fatty acid metabolism is implicated in cardiac dysfunction associated with refeeding syndrome.</div>
                
                
                
                
                
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/39310593" target="_blank">PMID:39310593</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"The abnormal metabolism of fatty acids was the presumed cause of cardiac dysfunction."</div>
                
                
                <div class="evidence-explanation">This cardiohistological case links abnormal fatty acid metabolism to cardiac dysfunction in refeeding syndrome.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
        </div>
        

        <!-- Histopathology -->
        
        <div class="card" id="histopathology">
            <div class="card-header">
                <div class="card-icon" style="background: #ffedd5; color: #c2410c;">✶</div>
                <h2 class="card-title">Histopathology</h2>
                <span class="card-count">1</span>
            </div>
            
            <div class="item-box histopathology-box">
                <div class="item-name">
                    Cardiomyocyte atrophy with nuclear swelling
                    
                </div>
                
                <div class="item-desc">Ventricular biopsy shows conspicuously atrophied cardiomyocytes with nuclear swelling and irregularities in refeeding syndrome with cardiac dysfunction.</div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/39310593" target="_blank">PMID:39310593</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"A histological examination showed conspicuously atrophied cardiomyocytes with nuclear swelling and irregularities"</div>
                
                
                <div class="evidence-explanation">This case report documents cardiomyocyte atrophy and nuclear changes on biopsy.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
        </div>
        

        <!-- Causal Graph -->
        

        <!-- Phenotypes -->
        
        <div class="card" id="phenotypes">
            <div class="card-header">
                <div class="card-icon" style="background: #dcfce7; color: #16a34a;">●</div>
                <h2 class="card-title">Phenotypes</h2>
                <span class="card-count">8</span>
            </div>
            
            
            <div class="pheno-toc">
                
                <a class="pheno-toc-pill" data-target="pheno-cat-1">Blood<span class="pill-count">(1)</span></a>
                
                <a class="pheno-toc-pill" data-target="pheno-cat-2">Cardiovascular<span class="pill-count">(2)</span></a>
                
                <a class="pheno-toc-pill" data-target="pheno-cat-3">Metabolism<span class="pill-count">(1)</span></a>
                
                <a class="pheno-toc-pill" data-target="pheno-cat-4">Nervous System<span class="pill-count">(2)</span></a>
                
                <a class="pheno-toc-pill" data-target="pheno-cat-5">Respiratory<span class="pill-count">(1)</span></a>
                
                <a class="pheno-toc-pill" data-target="pheno-cat-6">Other<span class="pill-count">(1)</span></a>
                
                <button class="pheno-toggle-all" id="phenoToggleAll">Expand all</button>
            </div>
            
            
            <details class="phenotype-category-group" id="pheno-cat-1">
                <summary>
                    <svg class="chevron" viewBox="0 0 16 16" fill="currentColor"><path d="M6 3l5 5-5 5V3z"/></svg>
                    Blood
                    <span class="cat-count">1</span>
                </summary>
                
                <div class="item-box phenotype-box">
                    <div class="item-name">
                        Pancytopenia
                        
                        <span class="phenotype-freq">OCCASIONAL</span>
                        
                        
                        <span class="phenotype-id">
                            <a href="http://purl.obolibrary.org/obo/HP_0001876" target="_blank">
                                Pancytopenia
                            </a>
                            <span style="font-size: 0.72rem; color: var(--text-muted);">(HP:0001876)</span>
                        </span>
                        
                    </div>
                    
                    
                    
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/41239620" target="_blank">PMID:41239620</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"Prolonged energy deficiency disrupts hematopoietic function, resulting in pancytopenia."</div>
                
                
                <div class="evidence-explanation">This case report notes pancytopenia in the context of severe malnutrition and refeeding syndrome.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
                    
    
    
                </div>
                
            </details>
            
            <details class="phenotype-category-group" id="pheno-cat-2">
                <summary>
                    <svg class="chevron" viewBox="0 0 16 16" fill="currentColor"><path d="M6 3l5 5-5 5V3z"/></svg>
                    Cardiovascular
                    <span class="cat-count">2</span>
                </summary>
                
                <div class="item-box phenotype-box">
                    <div class="item-name">
                        Arrhythmia
                        
                        <span class="phenotype-freq">OCCASIONAL</span>
                        
                        
                        <span class="phenotype-id">
                            <a href="http://purl.obolibrary.org/obo/HP_0011675" target="_blank">
                                Arrhythmia
                            </a>
                            <span style="font-size: 0.72rem; color: var(--text-muted);">(HP:0011675)</span>
                        </span>
                        
                    </div>
                    
                    
                    
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/19278172" target="_blank">PMID:19278172</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"Potential complications of RFS include fatal cardiac arrhythmia, systolic heart failure, respiratory insufficiency, and hematologic derangements."</div>
                
                
                <div class="evidence-explanation">This directly lists cardiac arrhythmia as a complication of refeeding syndrome.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
                    
    
    
                </div>
                
                <div class="item-box phenotype-box">
                    <div class="item-name">
                        Congestive Heart Failure
                        
                        <span class="phenotype-freq">OCCASIONAL</span>
                        
                        
                        <span class="phenotype-id">
                            <a href="http://purl.obolibrary.org/obo/HP_0001635" target="_blank">
                                Congestive heart failure
                            </a>
                            <span style="font-size: 0.72rem; color: var(--text-muted);">(HP:0001635)</span>
                        </span>
                        
                    </div>
                    
                    
                    
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/19278172" target="_blank">PMID:19278172</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"Potential complications of RFS include fatal cardiac arrhythmia, systolic heart failure, respiratory insufficiency, and hematologic derangements."</div>
                
                
                <div class="evidence-explanation">This lists systolic heart failure as a complication of refeeding syndrome.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
                    
    
    
                </div>
                
            </details>
            
            <details class="phenotype-category-group" id="pheno-cat-3">
                <summary>
                    <svg class="chevron" viewBox="0 0 16 16" fill="currentColor"><path d="M6 3l5 5-5 5V3z"/></svg>
                    Metabolism
                    <span class="cat-count">1</span>
                </summary>
                
                <div class="item-box phenotype-box">
                    <div class="item-name">
                        Edema
                        
                        <span class="phenotype-freq">OCCASIONAL</span>
                        
                        
                        <span class="phenotype-id">
                            <a href="http://purl.obolibrary.org/obo/HP_0000969" target="_blank">
                                Edema
                            </a>
                            <span style="font-size: 0.72rem; color: var(--text-muted);">(HP:0000969)</span>
                        </span>
                        
                    </div>
                    
                    
                    
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/19931071" target="_blank">PMID:19931071</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"Other metabolic abnormalities, such as hypokalemia and hypomagnesemia, may also occur, along with sodium and fluid retention."</div>
                
                
                <div class="evidence-explanation">Sodium and fluid retention during refeeding supports edema as a clinical manifestation.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
                    
    
    
                </div>
                
            </details>
            
            <details class="phenotype-category-group" id="pheno-cat-4">
                <summary>
                    <svg class="chevron" viewBox="0 0 16 16" fill="currentColor"><path d="M6 3l5 5-5 5V3z"/></svg>
                    Nervous System
                    <span class="cat-count">2</span>
                </summary>
                
                <div class="item-box phenotype-box">
                    <div class="item-name">
                        Seizures
                        
                        <span class="phenotype-freq">OCCASIONAL</span>
                        
                        
                        <span class="phenotype-id">
                            <a href="http://purl.obolibrary.org/obo/HP_0001250" target="_blank">
                                Seizure
                            </a>
                            <span style="font-size: 0.72rem; color: var(--text-muted);">(HP:0001250)</span>
                        </span>
                        
                    </div>
                    
                    
                    
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/41171118" target="_blank">PMID:41171118</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"RS itself becomes the cause of subsequent systemic complications such as respiratory failure, neurological disorders, circulatory failure or seizures."</div>
                
                
                <div class="evidence-explanation">This review lists seizures among systemic complications of refeeding syndrome.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
                    
    
    
                </div>
                
                <div class="item-box phenotype-box">
                    <div class="item-name">
                        Delirium
                        
                        <span class="phenotype-freq">COMMON</span>
                        
                        
                        <span class="phenotype-id">
                            <a href="http://purl.obolibrary.org/obo/HP_0031258" target="_blank">
                                Delirium
                            </a>
                            <span style="font-size: 0.72rem; color: var(--text-muted);">(HP:0031258)</span>
                        </span>
                        
                    </div>
                    
                    
                    
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (2 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/38054139" target="_blank">PMID:38054139</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"received total parenteral nutrition (TPN) on the first day, but this led to delirium due to refeeding syndrome."</div>
                
                
                <div class="evidence-explanation">This case report describes delirium attributed to refeeding syndrome after initiating TPN.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/39033818" target="_blank">PMID:39033818</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"The incidence of delirium in critically ill patients is high and associated with refeeding hypophosphatemia."</div>
                
                
                <div class="evidence-explanation">This retrospective study reports high delirium incidence associated with refeeding hypophosphatemia, supporting a common frequency.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
                    
    
    
                </div>
                
            </details>
            
            <details class="phenotype-category-group" id="pheno-cat-5">
                <summary>
                    <svg class="chevron" viewBox="0 0 16 16" fill="currentColor"><path d="M6 3l5 5-5 5V3z"/></svg>
                    Respiratory
                    <span class="cat-count">1</span>
                </summary>
                
                <div class="item-box phenotype-box">
                    <div class="item-name">
                        Respiratory Insufficiency
                        
                        <span class="phenotype-freq">OCCASIONAL</span>
                        
                        
                        <span class="phenotype-id">
                            <a href="http://purl.obolibrary.org/obo/HP_0002093" target="_blank">
                                Respiratory insufficiency
                            </a>
                            <span style="font-size: 0.72rem; color: var(--text-muted);">(HP:0002093)</span>
                        </span>
                        
                    </div>
                    
                    
                    
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/19278172" target="_blank">PMID:19278172</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"Potential complications of RFS include fatal cardiac arrhythmia, systolic heart failure, respiratory insufficiency, and hematologic derangements."</div>
                
                
                <div class="evidence-explanation">This directly lists respiratory insufficiency as a complication of refeeding syndrome.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
                    
    
    
                </div>
                
            </details>
            
            <details class="phenotype-category-group" id="pheno-cat-6">
                <summary>
                    <svg class="chevron" viewBox="0 0 16 16" fill="currentColor"><path d="M6 3l5 5-5 5V3z"/></svg>
                    Other
                    <span class="cat-count">1</span>
                </summary>
                
                <div class="item-box phenotype-box">
                    <div class="item-name">
                        Myocardial fibrosis and architectural disarray
                        
                        <span class="phenotype-freq">OCCASIONAL</span>
                        
                        
                    </div>
                    
                    
                    
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/39310593" target="_blank">PMID:39310593</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"the myocardial sequence was disturbed with fibrosis."</div>
                
                
                <div class="evidence-explanation">This case report notes fibrosis and architectural disturbance in myocardium.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
                    
    
    
                </div>
                
            </details>
            
            <script>
            (function() {
                // TOC pill click: expand target group and scroll to it
                document.querySelectorAll('.pheno-toc-pill').forEach(function(pill) {
                    pill.addEventListener('click', function() {
                        var target = document.getElementById(pill.dataset.target);
                        if (target) {
                            target.open = true;
                            target.scrollIntoView({behavior: 'smooth', block: 'start'});
                        }
                    });
                });
                // Expand/collapse all toggle
                var btn = document.getElementById('phenoToggleAll');
                if (btn) {
                    btn.addEventListener('click', function() {
                        var groups = document.querySelectorAll('.phenotype-category-group');
                        var anyOpen = Array.from(groups).some(function(g) { return g.open; });
                        groups.forEach(function(g) { g.open = !anyOpen; });
                        btn.textContent = anyOpen ? 'Expand all' : 'Collapse all';
                    });
                }
            })();
            </script>
            
        </div>
        

        <!-- Genetic Associations -->
        

        <!-- Treatments -->
        
        <div class="card" id="treatments">
            <div class="card-header">
                <div class="card-icon" style="background: #ede9fe; color: #7c3aed;">💊</div>
                <h2 class="card-title">Treatments</h2>
                <span class="card-count">4</span>
            </div>
            
            <div class="item-box treatment-box">
                <div class="item-name">
                    Controlled refeeding and caloric advancement
                    
                    <span class="phenotype-id">
                        <a href="https://bioregistry.io/MAXO:0000009" target="_blank">
                            MAXO:0000009
                        </a>
                    </span>
                    
                </div>
                
                <div class="item-desc">Gradual reintroduction of calories with careful monitoring to avoid rapid metabolic shifts.</div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (3 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://clinicaltrials.gov/study/NCT02488109" target="_blank">clinicaltrials:NCT02488109</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"The purpose of this study is to compare the efficacy, safety, and cost-effectiveness of lower calorie refeeding versus higher calorie refeeding in hospitalized adolescents with anorexia nervosa."</div>
                
                
                <div class="evidence-explanation">This trial evaluates caloric refeeding strategies, supporting controlled refeeding approaches.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/41171118" target="_blank">PMID:41171118</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"Current guidelines recommend a gradual increase in energy intake and regular monitoring of a patient&amp;apos;s metabolic status (especially phosphorus, potassium, and magnesium levels) during nutritional treatment."</div>
                
                
                <div class="evidence-explanation">This review supports gradual energy advancement during refeeding.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/41239620" target="_blank">PMID:41239620</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"LESSONS: A stepwise calorie escalation protocol effectively corrects hypophosphatemia in refeeding syndrome."</div>
                
                
                <div class="evidence-explanation">This case report supports stepwise caloric escalation during refeeding.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box treatment-box">
                <div class="item-name">
                    Electrolyte supplementation and monitoring
                    
                    <span class="phenotype-id">
                        <a href="https://bioregistry.io/MAXO:0000106" target="_blank">
                            MAXO:0000106
                        </a>
                    </span>
                    
                </div>
                
                <div class="item-desc">Repletion of phosphate, potassium, and magnesium with close monitoring of serum electrolytes during refeeding.</div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (2 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/41146174" target="_blank">PMID:41146174</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"Supplementation is indicated for severe or symptomatic cases, with oral therapy preferred for chronic conditions and intravenous routes for acute, severe hypophosphatemia."</div>
                
                
                <div class="evidence-explanation">This supports electrolyte supplementation as a management strategy for acute hypophosphatemia.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/41171118" target="_blank">PMID:41171118</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"Current guidelines recommend a gradual increase in energy intake and regular monitoring of a patient&amp;apos;s metabolic status (especially phosphorus, potassium, and magnesium levels) during nutritional treatment."</div>
                
                
                <div class="evidence-explanation">This review supports monitoring phosphorus, potassium, and magnesium during refeeding.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box treatment-box">
                <div class="item-name">
                    Thiamine (vitamin B1) supplementation
                    
                    <span class="phenotype-id">
                        <a href="https://bioregistry.io/MAXO:0010019" target="_blank">
                            MAXO:0010019
                        </a>
                    </span>
                    
                </div>
                
                <div class="item-desc">Thiamine supplementation prior to and during refeeding to prevent deficiency and related complications.</div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/29448987" target="_blank">PMID:29448987</a>
                    </span>
                    
                    <span class="evidence-support support-PARTIAL">PARTIAL</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"thiamine deficiency and disorder of sodium and fluid balance are common."</div>
                
                
                <div class="evidence-explanation">Thiamine deficiency is common during refeeding, supporting prophylactic supplementation.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box treatment-box">
                <div class="item-name">
                    Micronutrient supplementation during refeeding
                    
                    <span class="phenotype-id">
                        <a href="https://bioregistry.io/MAXO:0001262" target="_blank">
                            MAXO:0001262
                        </a>
                    </span>
                    
                </div>
                
                <div class="item-desc">Micronutrient supplementation during refeeding helps prevent deficiencies and refeeding syndrome.</div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/39947042" target="_blank">PMID:39947042</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"Benefits of early fasting responses have become clear, provided micronutrients are given to prevent deficiencies and refeeding syndrome."</div>
                
                
                <div class="evidence-explanation">This review supports providing micronutrients to prevent deficiencies and refeeding syndrome during nutrition management.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
        </div>
        

        <!-- Environmental Factors -->
        
        <div class="card">
            <div class="card-header">
                <div class="card-icon" style="background: #ccfbf1; color: #0d9488;">🌍</div>
                <h2 class="card-title">Environmental Factors</h2>
                <span class="card-count">4</span>
            </div>
            
            <div class="item-box environmental-box">
                <div class="item-name">Prolonged malnutrition or starvation</div>
                
                
                <div class="item-desc">Refeeding syndrome typically occurs after days to weeks of malnutrition or starvation followed by reintroduction of nutrition.</div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/19278172" target="_blank">PMID:19278172</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"The typical patient who experiences RFS has been malnourished for days to weeks and develops hypophosphatemia and, occasionally, hypokalemia and hypomagnesemia when administered a carbohydrate load in the form of glucose-containing fluids, total parenteral nutrition (TPN), tube feedings, or an oral diet."</div>
                
                
                <div class="evidence-explanation">This describes the malnutrition period preceding refeeding syndrome.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box environmental-box">
                <div class="item-name">Aggressive refeeding after malnutrition</div>
                
                
                <div class="item-desc">Rapid or aggressive enteral or parenteral feeding in a malnourished patient can precipitate refeeding syndrome.</div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/19931071" target="_blank">PMID:19931071</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"Refeeding syndrome (RFS) is the result of aggressive enteral or parenteral feeding in a malnourished patient, with hypophosphatemia being the hallmark of this phenomenon."</div>
                
                
                <div class="evidence-explanation">This supports aggressive refeeding in malnourished patients as a trigger.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box environmental-box">
                <div class="item-name">Severe acute malnutrition in hospitalized children</div>
                
                
                <div class="item-desc">Refeeding syndrome occurs during early nutritional management in inpatient children with severe acute malnutrition.</div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/41007088" target="_blank">PMID:41007088</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"Refeeding syndrome is a potentially fatal complication that occurs in inpatient, severely acutely malnourished children during the early phase of nutritional management."</div>
                
                
                <div class="evidence-explanation">This identifies severe acute malnutrition in hospitalized children as a high-risk setting.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box environmental-box">
                <div class="item-name">Severe mental illness with starvation</div>
                
                
                <div class="item-desc">Starvation associated with severe mental illness can precede refeeding syndrome during inpatient nutritional rehabilitation.</div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/40933623" target="_blank">PMID:40933623</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"This report highlights a case of schizophrenia-induced starvation and the potential development of RFS during an inpatient psychiatric hospitalization."</div>
                
                
                <div class="evidence-explanation">This documents severe mental illness with starvation as a risk context for RFS.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
        </div>
        

        <!-- Biochemical Markers -->
        
        <div class="card">
            <div class="card-header">
                <div class="card-icon" style="background: #fef3c7; color: #d97706;">🔬</div>
                <h2 class="card-title">Biochemical Markers</h2>
                <span class="card-count">3</span>
            </div>
            
            <div class="item-box biochemical-box">
                <div class="item-name">
                    Phosphate
                    
                    <span style="font-size: 0.8rem; font-weight: normal; opacity: 0.8;">(Decreased)</span>
                    
                </div>
                
                <div class="item-desc">Context: Refeeding syndrome after nutritional reintroduction</div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/19931071" target="_blank">PMID:19931071</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"Refeeding syndrome (RFS) is the result of aggressive enteral or parenteral feeding in a malnourished patient, with hypophosphatemia being the hallmark of this phenomenon."</div>
                
                
                <div class="evidence-explanation">This identifies hypophosphatemia as the hallmark biochemical feature.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box biochemical-box">
                <div class="item-name">
                    Potassium
                    
                    <span style="font-size: 0.8rem; font-weight: normal; opacity: 0.8;">(Decreased)</span>
                    
                </div>
                
                <div class="item-desc">Context: Refeeding syndrome after nutritional reintroduction</div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/19278172" target="_blank">PMID:19278172</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"The typical patient who experiences RFS has been malnourished for days to weeks and develops hypophosphatemia and, occasionally, hypokalemia and hypomagnesemia when administered a carbohydrate load in the form of glucose-containing fluids, total parenteral nutrition (TPN), tube feedings, or an oral diet."</div>
                
                
                <div class="evidence-explanation">This describes hypokalemia as an occasional electrolyte abnormality during refeeding syndrome.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box biochemical-box">
                <div class="item-name">
                    Magnesium
                    
                    <span style="font-size: 0.8rem; font-weight: normal; opacity: 0.8;">(Decreased)</span>
                    
                </div>
                
                <div class="item-desc">Context: Refeeding syndrome after nutritional reintroduction</div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/19278172" target="_blank">PMID:19278172</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"The typical patient who experiences RFS has been malnourished for days to weeks and develops hypophosphatemia and, occasionally, hypokalemia and hypomagnesemia when administered a carbohydrate load in the form of glucose-containing fluids, total parenteral nutrition (TPN), tube feedings, or an oral diet."</div>
                
                
                <div class="evidence-explanation">This identifies hypomagnesemia as an occasional electrolyte abnormality during refeeding syndrome.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
        </div>
        

        <!-- Differential Diagnoses -->
        
        <div class="card" id="differentials">
            <div class="card-header">
                <div class="card-icon" style="background: #fef2f2; color: #dc2626;">🔀</div>
                <h2 class="card-title">Differential Diagnoses</h2>
                <span class="card-count">3</span>
            </div>
            <p style="margin-bottom: 16px; font-size: 0.95rem; color: var(--text-muted);">
                Conditions with similar clinical presentations that must be differentiated from Refeeding Syndrome:
            </p>
            
            <div class="item-box differential-box">
                <div class="item-name">
                    Alcoholic ketoacidosis
                    
                    <span class="phenotype-id">
                        <a href="http://purl.obolibrary.org/obo/MONDO_0100160" target="_blank">
                            MONDO:0100160
                        </a>
                    </span>
                    
                </div>
                
                <div class="differential-similarities">
                    <strong>Overlapping Features</strong>
                    Acute metabolic derangement that can present with hypophosphatemia in high-risk settings and may overlap biochemically with refeeding syndrome.
                </div>
                
                
                <div class="differential-distinctions">
                    <strong>Distinguishing Features</strong>
                    
                    <ul>
                        
                        <li>Typically associated with heavy alcohol use and ketoacidosis rather than nutritional reintroduction.</li>
                        
                    </ul>
                    
                </div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/41146174" target="_blank">PMID:41146174</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"Phosphate measurement to evaluate acute hypophosphatemia is advised in high-risk settings: refeeding syndrome, hyperglycemic hyperosmolar syndrome, alcoholic ketoacidosis, worsening COPD or asthma exacerbations."</div>
                
                
                <div class="evidence-explanation">This identifies alcoholic ketoacidosis as a high-risk setting for acute hypophosphatemia.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box differential-box">
                <div class="item-name">
                    Hyperventilation-induced hypophosphatemia
                    
                    <span class="phenotype-id">
                        <a href="http://purl.obolibrary.org/obo/MONDO_0000313" target="_blank">
                            MONDO:0000313
                        </a>
                    </span>
                    
                </div>
                
                <div class="differential-similarities">
                    <strong>Overlapping Features</strong>
                    Respiratory alkalosis from hyperventilation can cause intracellular phosphate shifting and severe hypophosphatemia, mimicking refeeding-related electrolyte disturbances.
                </div>
                
                
                <div class="differential-distinctions">
                    <strong>Distinguishing Features</strong>
                    
                    <ul>
                        
                        <li>Hyperventilation with respiratory alkalosis drives phosphate shifts rather than nutritional reintroduction.</li>
                        
                    </ul>
                    
                </div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/41281097" target="_blank">PMID:41281097</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"One uncommon cause is hyperventilation-induced respiratory alkalosis, which promotes intracellular phosphate shifting and enhanced glycolysis, leading to depletion of serum phosphate."</div>
                
                
                <div class="evidence-explanation">This case report links hyperventilation-induced respiratory alkalosis to severe hypophosphatemia.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box differential-box">
                <div class="item-name">
                    Thyrotoxic periodic paralysis
                    
                    <span class="phenotype-id">
                        <a href="http://purl.obolibrary.org/obo/MONDO_0019201" target="_blank">
                            MONDO:0019201
                        </a>
                    </span>
                    
                </div>
                
                <div class="differential-similarities">
                    <strong>Overlapping Features</strong>
                    Thyrotoxic periodic paralysis can cause acute weakness with significant hypokalemia and may be confused with refeeding-related electrolyte shifts.
                </div>
                
                
                <div class="differential-distinctions">
                    <strong>Distinguishing Features</strong>
                    
                    <ul>
                        
                        <li>Occurs in the setting of thyrotoxicosis and paralysis with hypokalemia rather than refeeding.</li>
                        
                    </ul>
                    
                </div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/39896956" target="_blank">PMID:39896956</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"Thyrotoxic periodic paralysis (TPP) is a rare condition causing weakness of the lower extremities associated with significant hypokalemia."</div>
                
                
                <div class="evidence-explanation">This case report describes TPP with hypokalemia, supporting it as a differential in electrolyte-driven weakness.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
        </div>
        

        <!-- Datasets -->
        

        <!-- Clinical Trials -->
        
        <div class="card" id="trials">
            <div class="card-header">
                <div class="card-icon" style="background: #f5f3ff; color: #a855f7;">🔬</div>
                <h2 class="card-title">Clinical Trials</h2>
                <span class="card-count">2</span>
            </div>
            
            <div class="item-box clinical-trial-box">
                <div class="item-name">
                    NCT02488109
                    
                    <span class="tag tag-phase">NOT_APPLICABLE</span>
                    
                    
                    <span class="tag tag-status">COMPLETED</span>
                    
                </div>
                
                <div class="item-desc">Randomized trial comparing lower calorie versus higher calorie refeeding in hospitalized adolescents with anorexia nervosa.</div>
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://clinicaltrials.gov/study/NCT02488109" target="_blank">clinicaltrials:NCT02488109</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"The purpose of this study is to compare the efficacy, safety, and cost-effectiveness of lower calorie refeeding versus higher calorie refeeding in hospitalized adolescents with anorexia nervosa."</div>
                
                
                <div class="evidence-explanation">This trial evaluates refeeding strategies relevant to preventing refeeding complications.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box clinical-trial-box">
                <div class="item-name">
                    NCT04966858
                    
                    <span class="tag tag-phase">NOT_APPLICABLE</span>
                    
                    
                    <span class="tag tag-status">ENROLLING_BY_INVITATION</span>
                    
                </div>
                
                <div class="item-desc">Trial comparing individualized caloric refeeding to higher calorie refeeding in hospitalized patients with atypical anorexia nervosa.</div>
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://clinicaltrials.gov/study/NCT04966858" target="_blank">clinicaltrials:NCT04966858</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"The primary purpose of the trial is to compare the efficacy and safety of Individualized Caloric Refeeding (ICR) to the new standard of care, Higher Calorie Refeeding (HCR), in hospitalized patients with atypical anorexia nervosa (AAN), and clinical remission over one year of follow-up."</div>
                
                
                <div class="evidence-explanation">This trial directly compares refeeding protocols in a high-risk malnourished population.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
        </div>
        

        <!-- YAML Source -->
        <div class="card">
            <div class="card-header" style="cursor: pointer;" onclick="toggleYaml()">
                <div class="card-icon" style="background: #f1f5f9; color: #475569;">{ }</div>
                <h2 class="card-title">Source YAML</h2>
                <span class="card-count" id="yamlToggleText">click to show</span>
            </div>
            <div class="yaml-content" id="yamlContent">
                <pre class="yaml-preview">name: Refeeding Syndrome
description: &gt;-
  A potentially dangerous constellation of metabolic disturbances that occurs when
  nutrition is reintroduced after a period of malnutrition or starvation, often
  with carbohydrate-driven shifts in electrolytes and fluid balance.
category: Nutritional
disease_term:
  preferred_term: refeeding syndrome
  term:
    id: MONDO:0400005
    label: refeeding syndrome
parents:
- Nutritional Disorder
synonyms:
- re-feeding syndrome
- refeeding hypophosphatemia
- RFS
prevalence:
- population: General
  percentage: Unknown
  notes: Reported incidence is unknown and frequently underdiagnosed.
  evidence:
  - reference: PMID:29448987
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &#34;The incidence of RS is unknown as no universally accepted definition exists, but it is frequently underdiagnosed.&#34;
    explanation: This review states that the incidence is unknown and underdiagnosed.
- population: Adult patients receiving parenteral nutrition (Malaysia)
  percentage: 33.3
  notes: Retrospective cohort in a Malaysian teaching hospital (July 2022-July 2023).
  evidence:
  - reference: PMID:40738722
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &#34;Among 90 patients included, 30 (33.3%) developed RS.&#34;
    explanation: This provides an observed occurrence rate in a defined PN cohort.
- population: Severely acutely malnourished children (Sub-Saharan Africa inpatient)
  percentage: 8.7-34.8
  notes: Meta-analysis of inpatient children aged 6-59 months with severe acute malnutrition.
  evidence:
  - reference: PMID:41007088
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &#34;prevalence rates ranging from 8.7% to 34.8%.&#34;
    explanation: This meta-analysis reports the prevalence range of refeeding syndrome in inpatient SAM children.
- population: Hospitalized adult and elderly patients
  percentage: 38.8
  notes: Retrospective cross-sectional study in a university hospital.
  evidence:
  - reference: PMID:41173142
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &#34;A total of 121 patients were evaluated, of whom 38.8% presented with RS&#34;
    explanation: This study reports the proportion of hospitalized adult and elderly patients with refeeding syndrome.
pathophysiology:
- name: Pre-refeeding malnutrition state
  description: &gt;-
    Patients who develop refeeding syndrome typically have been malnourished for
    days to weeks before nutrition is reintroduced.
  evidence:
  - reference: PMID:19278172
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &#34;The typical patient who experiences RFS has been malnourished for days to weeks&#34;
    explanation: &gt;-
      This describes the malnourished state that precedes refeeding syndrome.
- name: Aggressive nutritional reintroduction
  description: &gt;-
    Refeeding syndrome is triggered when aggressive enteral or parenteral
    feeding is initiated in a malnourished patient.
  evidence:
  - reference: PMID:19931071
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &#34;Refeeding syndrome (RFS) is the result of aggressive enteral or parenteral feeding in a malnourished patient&#34;
    explanation: &gt;-
      This identifies aggressive refeeding in malnourished patients as the
      precipitating step.
- name: Hypophosphatemia as hallmark biochemical shift
  description: &gt;-
    Hypophosphatemia is the hallmark biochemical change following refeeding.
  evidence:
  - reference: PMID:19931071
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &#34;with hypophosphatemia being the hallmark of this phenomenon.&#34;
    explanation: &gt;-
      This explicitly labels hypophosphatemia as the hallmark feature of
      refeeding syndrome.
- name: Hypophosphatemia at onset of refeeding syndrome
  description: &gt;-
    Hypophosphatemia is observed at the onset of refeeding syndrome and is
    monitored during refeeding.
  evidence:
  - reference: PMID:36936877
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: &#34;Hypophosphatemia inevitably is observed at the onset of refeeding syndrome and therefore is monitored during refeeding&#34;
    explanation: &gt;-
      This notes that hypophosphatemia appears at onset and is monitored during
      refeeding.
- name: Intracellular electrolyte shift during anabolism
  description: &gt;-
    The metabolic response to refeeding drives an acute intracellular shift of
    electrolytes with increased phosphate demand for tissue anabolism and high-
    energy phosphate bond formation.
  evidence:
  - reference: PMID:19278172
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &#34;acute intracellular shift in electrolytes, increased phosphate demand during tissue anabolism, and formation of high-energy phosphate bonds.&#34;
    explanation: &gt;-
      This directly describes the intracellular electrolyte shift and increased
      phosphate demand that drive refeeding syndrome.
- name: Rapid post-feeding phosphate decline
  description: &gt;-
    After initiation of parenteral nutrition, phosphate levels decline rapidly
    and more markedly than potassium or magnesium.
  evidence:
  - reference: PMID:40738722
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &#34;Phosphate levels showed the most significant decline post-PN initiation (43%), followed by potassium (19%) and magnesium (17%)&#34;
    explanation: &gt;-
      This quantifies the rapid decline in phosphate compared with potassium and
      magnesium after PN initiation.
- name: Sodium and fluid retention
  description: &gt;-
    Sodium and fluid retention occurs alongside electrolyte abnormalities during
    refeeding.
  evidence:
  - reference: PMID:19931071
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &#34;along with sodium and fluid retention.&#34;
    explanation: &gt;-
      This identifies sodium and fluid retention as a common concurrent change.
- name: Thiamine deficiency emerges during refeeding
  description: &gt;-
    Thiamine deficiency is a common accompanying abnormality during refeeding.
  evidence:
  - reference: PMID:29448987
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &#34;thiamine deficiency and disorder of sodium and fluid balance are common.&#34;
    explanation: &gt;-
      This identifies thiamine deficiency as a common accompanying feature.
- name: Cardiorespiratory complications from metabolic derangements
  description: &gt;-
    Severe metabolic derangements can progress to fatal arrhythmias, systolic
    heart failure, and respiratory insufficiency.
  evidence:
  - reference: PMID:19278172
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &#34;fatal cardiac arrhythmia, systolic heart failure, respiratory insufficiency&#34;
    explanation: &gt;-
      This lists the severe cardiorespiratory complications of refeeding
      syndrome.
- name: Refeeding-induced central nervous system disorders
  description: &gt;-
    Refeeding can precipitate central nervous system complications including
    hypoglycemic encephalopathy, Wernicke encephalopathy, and hypophosphatemic
    encephalopathy.
  evidence:
  - reference: PMID:41246683
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &#34;Refeeding syndrome potentially causes death from refeeding-induced central nervous system disorders, such as hypoglycemic encephalopathy, Wernicke encephalopathy, and hypophosphatemic encephalopathy.&#34;
    explanation: This case report highlights CNS complications associated with refeeding syndrome.
- name: Abnormal myocardial fatty acid metabolism
  description: &gt;-
    Abnormal myocardial fatty acid metabolism is implicated in cardiac dysfunction
    associated with refeeding syndrome.
  evidence:
  - reference: PMID:39310593
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &#34;The abnormal metabolism of fatty acids was the presumed cause of cardiac dysfunction.&#34;
    explanation: This cardiohistological case links abnormal fatty acid metabolism to cardiac dysfunction in refeeding syndrome.
phenotypes:
- category: Cardiovascular
  name: Edema
  frequency: OCCASIONAL
  description: Sodium and fluid retention leading to edema during refeeding.
  phenotype_term:
    preferred_term: Edema
    term:
      id: HP:0000969
      label: Edema
  evidence:
  - reference: PMID:19931071
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &#34;Other metabolic abnormalities, such as hypokalemia and hypomagnesemia, may also occur, along with sodium and fluid retention.&#34;
    explanation: &gt;-
      Sodium and fluid retention during refeeding supports edema as a clinical
      manifestation.
- category: Cardiovascular
  name: Arrhythmia
  frequency: OCCASIONAL
  description: Cardiac rhythm disturbances related to electrolyte abnormalities.
  phenotype_term:
    preferred_term: Arrhythmia
    term:
      id: HP:0011675
      label: Arrhythmia
  evidence:
  - reference: PMID:19278172
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &#34;Potential complications of RFS include fatal cardiac arrhythmia, systolic heart failure, respiratory insufficiency, and hematologic derangements.&#34;
    explanation: &gt;-
      This directly lists cardiac arrhythmia as a complication of refeeding
      syndrome.
- category: Cardiovascular
  name: Congestive Heart Failure
  frequency: OCCASIONAL
  description: Systolic heart failure due to electrolyte shifts and fluid overload.
  phenotype_term:
    preferred_term: Congestive heart failure
    term:
      id: HP:0001635
      label: Congestive heart failure
  evidence:
  - reference: PMID:19278172
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &#34;Potential complications of RFS include fatal cardiac arrhythmia, systolic heart failure, respiratory insufficiency, and hematologic derangements.&#34;
    explanation: &gt;-
      This lists systolic heart failure as a complication of refeeding syndrome.
- category: Cardiovascular
  name: Myocardial fibrosis and architectural disarray
  frequency: OCCASIONAL
  description: Myocardial fibrosis and architectural disarray in refeeding syndrome-associated cardiac dysfunction.
  evidence:
  - reference: PMID:39310593
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &#34;the myocardial sequence was disturbed with fibrosis.&#34;
    explanation: This case report notes fibrosis and architectural disturbance in myocardium.
- category: Respiratory
  name: Respiratory Insufficiency
  frequency: OCCASIONAL
  description: Respiratory failure linked to severe electrolyte derangements.
  phenotype_term:
    preferred_term: Respiratory insufficiency
    term:
      id: HP:0002093
      label: Respiratory insufficiency
  evidence:
  - reference: PMID:19278172
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &#34;Potential complications of RFS include fatal cardiac arrhythmia, systolic heart failure, respiratory insufficiency, and hematologic derangements.&#34;
    explanation: &gt;-
      This directly lists respiratory insufficiency as a complication of
      refeeding syndrome.
- category: Hematological
  name: Pancytopenia
  frequency: OCCASIONAL
  description: Decrease in all blood cell lines during refeeding in severe malnutrition.
  phenotype_term:
    preferred_term: Pancytopenia
    term:
      id: HP:0001876
      label: Pancytopenia
  evidence:
  - reference: PMID:41239620
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &#34;Prolonged energy deficiency disrupts hematopoietic function, resulting in pancytopenia.&#34;
    explanation: This case report notes pancytopenia in the context of severe malnutrition and refeeding syndrome.
- category: Neurological
  name: Seizures
  frequency: OCCASIONAL
  description: Seizures as a systemic complication during refeeding syndrome.
  phenotype_term:
    preferred_term: Seizure
    term:
      id: HP:0001250
      label: Seizure
  evidence:
  - reference: PMID:41171118
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &#34;RS itself becomes the cause of subsequent systemic complications such as respiratory failure, neurological disorders, circulatory failure or seizures.&#34;
    explanation: This review lists seizures among systemic complications of refeeding syndrome.
- category: Neurological
  name: Delirium
  frequency: COMMON
  description: Delirium occurring after refeeding in a severely malnourished patient.
  phenotype_term:
    preferred_term: Delirium
    term:
      id: HP:0031258
      label: Delirium
  evidence:
  - reference: PMID:38054139
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &#34;received total parenteral nutrition (TPN) on the first day, but this led to delirium due to refeeding syndrome.&#34;
    explanation: This case report describes delirium attributed to refeeding syndrome after initiating TPN.
  - reference: PMID:39033818
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &#34;The incidence of delirium in critically ill patients is high and associated with refeeding hypophosphatemia.&#34;
    explanation: This retrospective study reports high delirium incidence associated with refeeding hypophosphatemia, supporting a common frequency.
biochemical:
- name: Phosphate
  presence: Decreased
  context: Refeeding syndrome after nutritional reintroduction
  biomarker_term:
    preferred_term: phosphate measurement
    term:
      id: NCIT:C64857
      label: Phosphate Measurement
  evidence:
  - reference: PMID:19931071
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &#34;Refeeding syndrome (RFS) is the result of aggressive enteral or parenteral feeding in a malnourished patient, with hypophosphatemia being the hallmark of this phenomenon.&#34;
    explanation: This identifies hypophosphatemia as the hallmark biochemical feature.
- name: Potassium
  presence: Decreased
  context: Refeeding syndrome after nutritional reintroduction
  biomarker_term:
    preferred_term: potassium measurement
    term:
      id: NCIT:C64853
      label: Potassium Measurement
  evidence:
  - reference: PMID:19278172
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &#34;The typical patient who experiences RFS has been malnourished for days to weeks and develops hypophosphatemia and, occasionally, hypokalemia and hypomagnesemia when administered a carbohydrate load in the form of glucose-containing fluids, total parenteral nutrition (TPN), tube feedings, or an oral diet.&#34;
    explanation: This describes hypokalemia as an occasional electrolyte abnormality during refeeding syndrome.
- name: Magnesium
  presence: Decreased
  context: Refeeding syndrome after nutritional reintroduction
  biomarker_term:
    preferred_term: magnesium measurement
    term:
      id: NCIT:C64840
      label: Magnesium Measurement
  evidence:
  - reference: PMID:19278172
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &#34;The typical patient who experiences RFS has been malnourished for days to weeks and develops hypophosphatemia and, occasionally, hypokalemia and hypomagnesemia when administered a carbohydrate load in the form of glucose-containing fluids, total parenteral nutrition (TPN), tube feedings, or an oral diet.&#34;
    explanation: This identifies hypomagnesemia as an occasional electrolyte abnormality during refeeding syndrome.
environmental:
- name: Prolonged malnutrition or starvation
  description: &gt;-
    Refeeding syndrome typically occurs after days to weeks of malnutrition or
    starvation followed by reintroduction of nutrition.
  evidence:
  - reference: PMID:19278172
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &#34;The typical patient who experiences RFS has been malnourished for days to weeks and develops hypophosphatemia and, occasionally, hypokalemia and hypomagnesemia when administered a carbohydrate load in the form of glucose-containing fluids, total parenteral nutrition (TPN), tube feedings, or an oral diet.&#34;
    explanation: &gt;-
      This describes the malnutrition period preceding refeeding syndrome.
- name: Aggressive refeeding after malnutrition
  description: &gt;-
    Rapid or aggressive enteral or parenteral feeding in a malnourished patient
    can precipitate refeeding syndrome.
  evidence:
  - reference: PMID:19931071
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &#34;Refeeding syndrome (RFS) is the result of aggressive enteral or parenteral feeding in a malnourished patient, with hypophosphatemia being the hallmark of this phenomenon.&#34;
    explanation: &gt;-
      This supports aggressive refeeding in malnourished patients as a trigger.
- name: Severe acute malnutrition in hospitalized children
  description: &gt;-
    Refeeding syndrome occurs during early nutritional management in inpatient
    children with severe acute malnutrition.
  evidence:
  - reference: PMID:41007088
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &#34;Refeeding syndrome is a potentially fatal complication that occurs in inpatient, severely acutely malnourished children during the early phase of nutritional management.&#34;
    explanation: This identifies severe acute malnutrition in hospitalized children as a high-risk setting.
- name: Severe mental illness with starvation
  description: &gt;-
    Starvation associated with severe mental illness can precede refeeding
    syndrome during inpatient nutritional rehabilitation.
  evidence:
  - reference: PMID:40933623
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &#34;This report highlights a case of schizophrenia-induced starvation and the potential development of RFS during an inpatient psychiatric hospitalization.&#34;
    explanation: This documents severe mental illness with starvation as a risk context for RFS.
treatments:
- name: Controlled refeeding and caloric advancement
  description: &gt;-
    Gradual reintroduction of calories with careful monitoring to avoid rapid
    metabolic shifts.
  treatment_term:
    preferred_term: nutrition intervention
    term:
      id: MAXO:0000009
      label: nutrition intervention
  evidence:
  - reference: clinicaltrials:NCT02488109
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: The purpose of this study is to compare the efficacy, safety, and cost-effectiveness of lower calorie refeeding versus higher calorie refeeding in hospitalized adolescents with anorexia nervosa.
    explanation: This trial evaluates caloric refeeding strategies, supporting controlled refeeding approaches.
  - reference: PMID:41171118
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &#34;Current guidelines recommend a gradual increase in energy intake and regular monitoring of a patient&amp;apos;s metabolic status (especially phosphorus, potassium, and magnesium levels) during nutritional treatment.&#34;
    explanation: This review supports gradual energy advancement during refeeding.
  - reference: PMID:41239620
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &#34;LESSONS: A stepwise calorie escalation protocol effectively corrects hypophosphatemia in refeeding syndrome.&#34;
    explanation: This case report supports stepwise caloric escalation during refeeding.
- name: Electrolyte supplementation and monitoring
  description: &gt;-
    Repletion of phosphate, potassium, and magnesium with close monitoring of
    serum electrolytes during refeeding.
  treatment_term:
    preferred_term: nutritional supplementation
    term:
      id: MAXO:0000106
      label: nutritional supplementation
  evidence:
  - reference: PMID:41146174
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &#34;Supplementation is indicated for severe or symptomatic cases, with oral therapy preferred for chronic conditions and intravenous routes for acute, severe hypophosphatemia.&#34;
    explanation: This supports electrolyte supplementation as a management strategy for acute hypophosphatemia.
  - reference: PMID:41171118
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &#34;Current guidelines recommend a gradual increase in energy intake and regular monitoring of a patient&amp;apos;s metabolic status (especially phosphorus, potassium, and magnesium levels) during nutritional treatment.&#34;
    explanation: This review supports monitoring phosphorus, potassium, and magnesium during refeeding.
- name: Thiamine (vitamin B1) supplementation
  description: &gt;-
    Thiamine supplementation prior to and during refeeding to prevent deficiency
    and related complications.
  treatment_term:
    preferred_term: vitamin B1 supplementation
    term:
      id: MAXO:0010019
      label: vitamin B1 supplementation
  evidence:
  - reference: PMID:29448987
    supports: PARTIAL
    evidence_source: HUMAN_CLINICAL
    snippet: &#34;thiamine deficiency and disorder of sodium and fluid balance are common.&#34;
    explanation: Thiamine deficiency is common during refeeding, supporting prophylactic supplementation.
- name: Micronutrient supplementation during refeeding
  description: &gt;-
    Micronutrient supplementation during refeeding helps prevent deficiencies
    and refeeding syndrome.
  treatment_term:
    preferred_term: micronutrient supplementation
    term:
      id: MAXO:0001262
      label: micronutrient supplementation
  evidence:
  - reference: PMID:39947042
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &#34;Benefits of early fasting responses have become clear, provided micronutrients are given to prevent deficiencies and refeeding syndrome.&#34;
    explanation: This review supports providing micronutrients to prevent deficiencies and refeeding syndrome during nutrition management.
diagnosis:
- name: Electrolyte decline after refeeding
  description: &gt;-
    Refeeding syndrome defined by a &gt;10% decrease in serum phosphorus, potassium,
    or magnesium within 5 days after refeeding in ICU patients.
  markers: Phosphorus, potassium, magnesium
  evidence:
  - reference: PMID:41113144
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &#34;RFS was defined as a &gt;10% decrease in serum phosphorus, potassium, or magnesium within 5 days after refeeding.&#34;
    explanation: This provides a diagnostic definition used in an ICU risk model study.
notes: &gt;-
  Refeeding syndrome is preventable with careful risk assessment, slow caloric
  advancement, and proactive electrolyte and vitamin replacement.
histopathology:
- name: Cardiomyocyte atrophy with nuclear swelling
  description: &gt;-
    Ventricular biopsy shows conspicuously atrophied cardiomyocytes with nuclear
    swelling and irregularities in refeeding syndrome with cardiac dysfunction.
  evidence:
  - reference: PMID:39310593
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &#34;A histological examination showed conspicuously atrophied cardiomyocytes with nuclear swelling and irregularities&#34;
    explanation: This case report documents cardiomyocyte atrophy and nuclear changes on biopsy.
differential_diagnoses:
  - name: Alcoholic ketoacidosis
    disease_term:
      preferred_term: alcoholic ketoacidosis
      term:
        id: MONDO:0100160
        label: alcoholic ketoacidosis
    description: &gt;-
      Acute metabolic derangement that can present with hypophosphatemia in high-risk
      settings and may overlap biochemically with refeeding syndrome.
    distinguishing_features:
      - Typically associated with heavy alcohol use and ketoacidosis rather than nutritional reintroduction.
    evidence:
      - reference: PMID:41146174
        supports: SUPPORT
        evidence_source: HUMAN_CLINICAL
        snippet: &#34;Phosphate measurement to evaluate acute hypophosphatemia is advised in high-risk settings: refeeding syndrome, hyperglycemic hyperosmolar syndrome, alcoholic ketoacidosis, worsening COPD or asthma exacerbations.&#34;
        explanation: This identifies alcoholic ketoacidosis as a high-risk setting for acute hypophosphatemia.
  - name: Hyperventilation-induced hypophosphatemia
    disease_term:
      preferred_term: hypophosphatemia
      term:
        id: MONDO:0000313
        label: hypophosphatemia
    description: &gt;-
      Respiratory alkalosis from hyperventilation can cause intracellular
      phosphate shifting and severe hypophosphatemia, mimicking refeeding-related
      electrolyte disturbances.
    distinguishing_features:
      - Hyperventilation with respiratory alkalosis drives phosphate shifts rather than nutritional reintroduction.
    evidence:
      - reference: PMID:41281097
        supports: SUPPORT
        evidence_source: HUMAN_CLINICAL
        snippet: &#34;One uncommon cause is hyperventilation-induced respiratory alkalosis, which promotes intracellular phosphate shifting and enhanced glycolysis, leading to depletion of serum phosphate.&#34;
        explanation: This case report links hyperventilation-induced respiratory alkalosis to severe hypophosphatemia.
  - name: Thyrotoxic periodic paralysis
    disease_term:
      preferred_term: thyrotoxic periodic paralysis
      term:
        id: MONDO:0019201
        label: thyrotoxic periodic paralysis
    description: &gt;-
      Thyrotoxic periodic paralysis can cause acute weakness with significant
      hypokalemia and may be confused with refeeding-related electrolyte shifts.
    distinguishing_features:
      - Occurs in the setting of thyrotoxicosis and paralysis with hypokalemia rather than refeeding.
    evidence:
      - reference: PMID:39896956
        supports: SUPPORT
        evidence_source: HUMAN_CLINICAL
        snippet: &#34;Thyrotoxic periodic paralysis (TPP) is a rare condition causing weakness of the lower extremities associated with significant hypokalemia.&#34;
        explanation: This case report describes TPP with hypokalemia, supporting it as a differential in electrolyte-driven weakness.
clinical_trials:
  - name: NCT02488109
    phase: NOT_APPLICABLE
    status: COMPLETED
    description: Randomized trial comparing lower calorie versus higher calorie refeeding in hospitalized adolescents with anorexia nervosa.
    evidence:
      - reference: clinicaltrials:NCT02488109
        supports: SUPPORT
        evidence_source: HUMAN_CLINICAL
        snippet: The purpose of this study is to compare the efficacy, safety, and cost-effectiveness of lower calorie refeeding versus higher calorie refeeding in hospitalized adolescents with anorexia nervosa.
        explanation: This trial evaluates refeeding strategies relevant to preventing refeeding complications.
  - name: NCT04966858
    phase: NOT_APPLICABLE
    status: ENROLLING_BY_INVITATION
    description: Trial comparing individualized caloric refeeding to higher calorie refeeding in hospitalized patients with atypical anorexia nervosa.
    evidence:
      - reference: clinicaltrials:NCT04966858
        supports: SUPPORT
        evidence_source: HUMAN_CLINICAL
        snippet: The primary purpose of the trial is to compare the efficacy and safety of Individualized Caloric Refeeding (ICR) to the new standard of care, Higher Calorie Refeeding (HCR), in hospitalized patients with atypical anorexia nervosa (AAN), and clinical remission over one year of follow-up.
        explanation: This trial directly compares refeeding protocols in a high-risk malnourished population.
</pre>
            </div>
        </div>

        <footer class="page-footer">
            <p>
                Generated from <a href="https://github.com/monarch-initiative/dismech" target="_blank">dismech</a>
                knowledge base
            </p>
            <p style="margin-top: 8px;">
                <a href="https://github.com/monarch-initiative/dismech/blob/main/kb/disorders/Refeeding_Syndrome.yaml" target="_blank">View source on GitHub</a>
            </p>
        </footer>
    </div>

    <script>
        function toggleYaml() {
            const content = document.getElementById('yamlContent');
            const toggleText = document.getElementById('yamlToggleText');
            content.classList.toggle('show');
            toggleText.textContent = content.classList.contains('show') ? 'click to hide' : 'click to show';
        }
    </script>
    <script>
        (function() {
            const banner = document.querySelector('.notice-banner');
            if (!banner) return;
            const dismiss = () => banner.remove();
            banner.addEventListener('click', dismiss);
            banner.addEventListener('keydown', (event) => {
                if (event.key === 'Enter' || event.key === ' ') {
                    event.preventDefault();
                    dismiss();
                }
            });
        })();
    </script>
</body>
</html>